MIAMI--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that Robert C. Strauss, its President, CEO & Chairman, is scheduled to provide an update on Noven’s business and prospects at the UBS Global Generic and Specialty Pharmaceuticals Conference in New York City on Wednesday, May 9, 2007, at 9:30 a.m. Eastern Time. The public is invited to listen to the presentation live via webcast at www.noven.com, and a replay will be available for at least two weeks at the same site.
